# Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone

Study · id `cardio:ct-nct00965406` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT00965406](<https://clinicaltrials.gov/study/NCT00965406>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT00965406

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 772 participants.

## Technical summary

Registry record NCT00965406. Randomized; single masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2013-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 772 participants (enrolled count; ClinicalTrials.gov record NCT00965406, source copy `cardio:ctgov-nct00965406-2017-05-02`, retrieved 2026-10-31)
- Start date: 2010-08 (registry gives no type) (ClinicalTrials.gov record NCT00965406, source copy `cardio:ctgov-nct00965406-2017-05-02`, retrieved 2026-10-31)
- Primary completion: 2013-12 (actual) (ClinicalTrials.gov record NCT00965406, source copy `cardio:ctgov-nct00965406-2017-05-02`, retrieved 2026-10-31)
- Completion: 2014-06 (actual) (ClinicalTrials.gov record NCT00965406, source copy `cardio:ctgov-nct00965406-2017-05-02`, retrieved 2026-10-31)
- Countries: Tunisia (ClinicalTrials.gov record NCT00965406, source copy `cardio:ctgov-nct00965406-2017-05-02`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct00965406-2017-05-02`, retrieved 2026-10-31)

## The registry's words

- Brief title: Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone
- Condition: Acute Coronary Syndrome
- Intervention (Drug): GIK and intensive insulin therapy
- Lead sponsor: University of Monastir
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: University of Monastir (`cardio:org-university-of-monastir`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: One-Year Outcome of Intensive Insulin Therapy Combined to Glucose-Insulin-Potassium in Acute Coronary Syndrome: A Randomized Controlled Study (`cardio:pubmed-29138181`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ead08f70b77738cd1e8ea31a356084603ba614d47b9cad604a59f59a242acaca
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
